Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
62.839,90
-0,08%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ IGM Biosciences Inc (IGMS) IGM Biosciences Inc (IGMS) Notizie

IGM Biosciences Inc

IGMS
10,07
0,64 (6,79%)
03 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
17/4/202414:30GLOBEIGM Biosciences Announces Refocusing of Sanofi Collaboration
10/4/202413:00GLOBEIGM Biosciences to Present at the Stifel 2024 Virtual..
07/3/202422:27EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/3/202422:10EDGAR2Form 8-K - Current report
07/3/202422:10GLOBEIGM Biosciences Announces Fourth Quarter and Full Year 2023..
06/3/202401:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202413:00GLOBEIGM Biosciences to Present at the Guggenheim Healthcare..
08/1/202415:00EDGAR2Form 8-K - Current report
04/1/202402:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202400:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202400:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202413:00GLOBEIGM Biosciences to Present at the 42nd Annual J.P. Morgan..
16/12/202301:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202301:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202301:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202323:36EDGAR2Form 144 - Report of proposed sale of securities
13/12/202323:33EDGAR2Form 144 - Report of proposed sale of securities
13/12/202323:30EDGAR2Form 144 - Report of proposed sale of securities
13/12/202323:27EDGAR2Form 144 - Report of proposed sale of securities
08/12/202322:05EDGAR2Form 8-K - Current report
05/12/202322:01GLOBEIGM Biosciences Announces Strategic Pipeline Prioritization..
02/12/202301:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202301:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202301:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202311:32PRNUSBulletin from Extraordinary General Meeting in Medivir AB..
30/11/202302:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/11/202302:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/11/202302:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
21/11/202308:48PRNUSMedivir to present at the Erik Penser Bank Company Event
13/11/202323:08EDGAR2Form S-3 - Registration statement under Securities Act of..
13/11/202322:10EDGAR2Form 8-K - Current report
13/11/202322:10GLOBEIGM Biosciences Announces Third Quarter 2023 Financial..
13/11/202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202313:00GLOBEIGM Biosciences to Present at Two Upcoming Investor..
06/10/202301:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/10/202301:42EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/10/202313:29PRNUSFostrox + Lenvima continues to show promising tumor control..
04/10/202302:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202301:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202301:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202301:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202322:14EDGAR2Form 8-K - Current report
03/10/202322:05GLOBEIGM Biosciences Announces Retirement of Chairman Michael..
02/10/202322:27EDGAR2Form 144 - Report of proposed sale of securities
06/9/202313:00GLOBEIGM Biosciences to Present at the Morgan Stanley 21st Annual..
03/8/202322:13EDGAR2Form 8-K - Current report
03/8/202322:10GLOBEIGM Biosciences Announces Second Quarter 2023 Financial..
03/8/202322:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
19/7/202322:13EDGAR2Form SC 13D/A - General statement of acquisition of..
Apertura: 9,73 Min: 9,72 Max: 10,19
Chiusura: 9,43

La tua Cronologia

NASDAQ
IGMS
IGM Biosciences
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network